OncoImmunology
Volume 9, 2020 - Issue 1
Open access
3,560
Views
36
CrossRef citations to date
0
Altmetric
Back Matter
Nanovaccine administration route is critical to obtain pertinent iNKt cell help for robust anti-tumor T and B cell responses
Yusuf Dölena Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center & Oncode Institute, Nijmegen, The NetherlandsView further author information
, Michael Valentea Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center & Oncode Institute, Nijmegen, The NetherlandsView further author information
, Oya Tagita Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center & Oncode Institute, Nijmegen, The NetherlandsView further author information
, Eliezer Jägerb Institute of Macromolecular Chemistry V.v.i., Academy of Sciences of the Czech Republic, Prague 6, Czech RepublicView further author information
, Eric A. W. Van Dinthera Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center & Oncode Institute, Nijmegen, The NetherlandsView further author information
, N. Koen van Riessena Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center & Oncode Institute, Nijmegen, The NetherlandsView further author information
, Martin Hrubyb Institute of Macromolecular Chemistry V.v.i., Academy of Sciences of the Czech Republic, Prague 6, Czech RepublicView further author information
, Uzi Gileadic MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UKView further author information
, Vincenzo Cerundoloc MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UKView further author information
& Carl G. Figdora Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center & Oncode Institute, Nijmegen, The NetherlandsCorrespondence[email protected]
View further author information
show allView further author information
Article: 1738813
|
Received 07 Aug 2019, Accepted 16 Jan 2020, Published online: 17 Mar 2020
Reprints and Permissions
This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.
You are not required to obtain permission to reuse this article in part or whole.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.